Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Not Yet Recruiting

A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)

NCT07614022

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Atrium Health Levine Cancer Charlotte, North Carolina, United States

Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Not Yet Recruiting

Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).

NCT07624799

Conditions: CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia

NCT07623655

Conditions: Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase I Study of FXS0683 in the Treatment of Blood Tumors

NCT07616089

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma, +18 more
Locations: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

U96-CAR-T-Cells For R/R B-ALL

NCT07511426

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

NCT07573111

Conditions: Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +14 more
Locations: Lucille Packard Children's Hospital of Stanford University Palo Alto, California, United States

View Trial Details

Not Yet Recruiting

Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission

NCT07577531

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT07582159

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

View Trial Details

Not Yet Recruiting

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

NCT07301424

Conditions: Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia, Hematologic Diseases, +10 more
Locations: University of Alberta Edmonton, Alberta, Canada

View Trial Details

Not Yet Recruiting

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

NCT07178912

Conditions: Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions